Setmelanotide

Imcivree

10 MG / ML SolutionCanadaMarketedAuthorised 12 Jul 2023

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Imcivree 10 MG/ML Solucion InyectableSpain · 10 mg · solución inyectable · Rhythm Pharmaceuticals Netherlands B.V.Same brand
ImcivreeEuropean Union · Rhythm Pharmaceuticals Netherlands B.V.Same brand
ImcivreeCroatiaSame brand
ImcivreeItaly · Soluzione iniettabile · Rhythm Pharmaceuticals Netherlands B.V.Same brand
Imcivree 10 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Rhythm Pharmaceuticals Netherlands B.V.Same brand
ImcivreeUnited States · 10MG BASE/ML · solution · RhythmSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Setmelanotide

Imcivree

10 MG / ML SolutionCanadaMarketedAuthorised 12 Jul 2023

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Setmelanotide
Strength: 10 MG / ML
Dosage form: Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 12 Jul 2023
Registration: DIN 02537745
Marketing authorisation holder: Rhythm Pharmaceuticals, INC.
ATC code: A08AA12
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION